Advertisement

Topics

RARE Disappoints, NSPR Put On Notice, PMD Launches Synthetic Cannabinoids Test

02:01 EDT 23 Aug 2017 | RTTNews

Today's Daily Dose brings you news about InspireMD's listing deficiency; MabVax's exploration of strategic alternatives; Novogen's progress in developing GDC-008 in glioblastoma; Psychemedics' launch of Synthetic Cannabinoids test and disappointing results from Ultragenyx's GNE Myopathy trial.

Original Article: RARE Disappoints, NSPR Put On Notice, PMD Launches Synthetic Cannabinoids Test

NEXT ARTICLE

More From BioPortfolio on "RARE Disappoints, NSPR Put On Notice, PMD Launches Synthetic Cannabinoids Test"

Advertisement
Quick Search
Advertisement
Advertisement